BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12787433)

  • 1. Mycophenolate mofetil prevents development of urinary protein in autoimmune nephritis.
    Takeda S; Takahashi M; Kusano E; Kobayashi E
    Kidney Int; 2003 Jul; 64(1):365-6; author reply 366. PubMed ID: 12787433
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of mycophenolate mofetil in mercury-induced autoimmune nephritis.
    Nieto E; Escudero E; Navarro E; Yáñez-Mo M; Martín A; Pérez de Lema G; Sánchez-Madrid F; Mampaso F
    J Am Soc Nephrol; 2002 Apr; 13(4):937-945. PubMed ID: 11912253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with mycophenolate mofetil attenuates the development of Heymann nephritis.
    Luca ME; Paul LC; van Der Wal AM; Bruijn JA; de Heer E
    Exp Nephrol; 2000; 8(2):77-83. PubMed ID: 10729746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs: 9. Mycophenolate mofetil].
    Kono M; Atsumi T
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2954-9. PubMed ID: 22175137
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent.
    Talhari C; Mahnke N; Ruzicka T; Megahed M
    Clin Exp Dermatol; 2005 May; 30(3):297-8. PubMed ID: 15807696
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil monotherapy for pemphigus vulgaris.
    Bredlich RO; Grundmann-Kollmann M; Behrens S; Kerscher M; Peter RU
    Br J Dermatol; 1999 Nov; 141(5):934. PubMed ID: 10583186
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycophenolate mofetil for the treatment of autoimmune diseases: hype or hope?
    Daikeler T
    Swiss Med Wkly; 2009 Jan; 139(3-4):34. PubMed ID: 19169900
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of remission in a child with autoimmune enteropathy using mycophenolate mofetil.
    Quirós-Tejeira RE; Ament ME; Vargas JH
    J Pediatr Gastroenterol Nutr; 2003 Apr; 36(4):482-5. PubMed ID: 12658040
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycophenolate mofetil: new applications for this immunosuppressant.
    Moder KG
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):15-19; quiz 20, 78. PubMed ID: 12546332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of lupus nephritis with mycophenolate mofetil].
    Celić D; Ilić T; Durdević-Mirković T; Mitić I; Milić B; Curić S
    Med Pregl; 2007; 60 Suppl 2():124-7. PubMed ID: 18928177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-transplant uses of mycophenolate mofetil.
    Jayne D
    Curr Opin Nephrol Hypertens; 1999 Sep; 8(5):563-7. PubMed ID: 10541218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases?
    Iaccarino L; Rampudda M; Canova M; Della Libera S; Sarzi-Puttinic P; Doria A
    Autoimmun Rev; 2007 Jan; 6(3):190-5. PubMed ID: 17289556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial nephritis and autoimmune pancreatitis: a case report.
    Merkle M; Gröne HJ
    Int Urol Nephrol; 2012 Feb; 44(1):319-22. PubMed ID: 21069569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mycophenolate mofetil--a new therapeutic agent for chronic autoimmune diseases].
    Harboe E; Gøransson L; Wildhagen K; Omdal R
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1650-2. PubMed ID: 15976831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil in animal models of autoimmune disease.
    Zandman-Goddard G; Shoenfeld Y
    Lupus; 2005; 14 Suppl 1():s12-6. PubMed ID: 15803926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil prevents autoimmune glomerulonephritis and alterations of intrarenal adrenomedullin in rats.
    Shi Y; Yoshihara F; Nakahama H; Goto R; Sada M; Kawano Y; Moriyama T; Yazawa K; Ichimaru N; Takahara S; Kangawa K
    Eur J Pharmacol; 2004 Apr; 489(1-2):127-33. PubMed ID: 15063164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of lupus nephritis during treatment with mycophenolate mofetil.
    Ahmadi-Simab K; Lamprecht P; Gross WL
    Ann Rheum Dis; 2004 Sep; 63(9):1179-80. PubMed ID: 15308535
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis.
    Killen JP
    N Engl J Med; 2006 Feb; 354(7):764-5; author reply 764-5. PubMed ID: 16482673
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis.
    Karassa FB
    N Engl J Med; 2006 Feb; 354(7):764-5; author reply 764-5. PubMed ID: 16481648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.